MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia

British Journal of Ophthalmology

Volumn 82, Issue 11, 1998, Pages 1316-1319

  Chowers, Itay ^a   Livni, Nelly ^a   Solomon, Abraham ^a   Zajicek, Gershom ^a   Frucht Pery, Joseph ^a   Folberg, Robert ^b   Pe'er, Jacob ^a,c  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF IOWA   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; FORMALDEHYDE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PARAFFIN;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOSIS; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY; STAINING;

EID: 0031755511     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.11.1316     Document Type: Article

References (19)

1. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985;16:129-35.
2. Folberg R, McLean IW, Zimmerman LE. Conjunctival melanosis and melanoma. Ophthalmology 1984;91:673-8.
3. Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva. Hum Pathol 1986;17:652-4.
4. Folberg R. Tumor progression in ocular melanoma. J Invest Dermatol 1993;100:326S-31S.
5. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989;96:147-66.
6. Yu CCW, Filipe MI. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 1993;25: 843-53
7. Seregard S. Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma. J Clin Pathol 1996;49:338-42.
8. Hitchcock CL. Ki-67 staining as a means to simplify analysis of tumor cell proliferation. Am J Clin Pathol 1991;96: 444-6.
9. Karlsson M, Boeryd B, Carstensen J, et al. Correlation of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer 1996;32A:357-62.
10. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin section: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
11. Shivji KK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992;69: 367-74.
12. Bradenstein DS, Char DH, Kaleta-Michaels S, et al. Ki-67 and bromodeoxyuridine labeling of human choroidal melanoma cells. Curr Eye Res 1991;10:479-84.
13. Bulten J, Van Der Laak JAWM, Gemmink JH, et al. MIB-1, a promising marker for the classification of cervical intraepithelial neoplasia. J Pathol 1996;178:268-73.
14. Rieger E, Hofmann-Wellenhof R, Soyer P, et al. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. J Cutan Pathol 1993;20:229-36.
15. Fogt F, Vortmeyer AO, Tahan SR. Nuclear organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneus melanocytic lesions. Am J Dermatopathol 1995;17:12-17.
16. Seregard S, Oskarsson M, Spangberg B. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma. Invest Ophthalmol Vis Sci 1996;37:1451-8.
17. Mooy CM, de Jong PTVM, Van Der Kwast TH, et al. Ki-67 immunostaining in uveal melanoma. Ophthalmology 1990; 97:1275-80.
18. Pe'er J, Gnessin H, Shargal Y, et al. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Ophthalmology 1994;101:56-62.
19. Seregard S. Cell proliferation as a prognostic indicator in conjunctival malignant melanoma. Am J Ophthalmol 1993; 116:93-7.